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Cytotoxic T lymphocytes (CTLs) are prominent components of immune de-
fenses against virus infections because of their ability to destroy virus-infected
cells . Extensive studies indicate that when the cells of cloned murine CTL cell
lines adhere to and recognize epitopes on another cell (a target cell), dense
cytoplasmic granules within the CTL migrate towards and discharge their
contents at theCTL target cell junction (reviewed in reference 1) . One compo-
nent ofthe granules is a complement (C9)-likehemolytic protein (termed perforin
[2-6] or cytolysin [I]) that can form nonspecific ion channels in cell membranes ;
the subsequent massive changes in intracellular concentrations ofCa2' and other
ions are probably responsible for target cell death (7-9) . The granules also
contain large amounts of a neutral serine esterase that cleaves the synthetic lysine
derivative benzyloxycarbonyl-L-lysine-thiobenzyl ester (BLT)' (10-13). The en-
zyme (referred to here as BLT-serine esterase) is one of the most abundant
proteins (-I%) in murine CTL cell lines; although its function, and that of
several other granule-associated serine esterases, is unknown, some evidence
suggests that it may also be involved in target cell destruction (10, 11, 13, 14) .
If these molecules are essential for granule-dependent cytolytic activity, homol-
ogous proteins would be expected to be present in the CTLs from diverse species .
Do cloned human CTL cell lines express the BLT-serine esterase and hemolytic
activities that areso prominent in murine CTL cell lines? To answer this question,
we have tested several cloned human CTL cell lines for the presence of serine
esterase and hemolytic granules . Our results show that human CTLs have a
serine esterase homologous to the murine enzyme, albeit at about one-tenth the
level found in the corresponding murine cloned cell lines, but we were unable
to detect any evidence of hemolytic activity in the human cells . The findings
suggest that an alternative mechanism of target cell lysis may be employed by
the human CTLs examined .
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' Abbreviations used in this paper:
￿
BLT, benzyloxycarbonyl-L-lysine-thiobenzyl ester ; DFP, diiso-
propylfluorophosphoridate; DTNB, 5,5'-dithiobis-(2-nitrobenzoic acid) ; TLCK, N-a-p-tosyl-L-lysine
chloromethyl ketone ; TPCK, N-tosyl-L-phenylalanine chloromethyl ketone .
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Materials and Methods
MixedLymphocyte Culture.
￿
Venous blood was sterilely collected from humanvolunteers
andanticoagulated with sodium heparin (25 U/ml; Ellins-Sims, Inc., Cherry Hill, NJ); the
blood was mixed with an equal volume of RPMI 1640, then layeredover Ficoll-Hypaque
(Pharmacia Fine Chemicals, Piscataway, NJ) and centrifuged at 2,500 rpm for 15 min.
Cells at the Ficoll-serum interface were collected, washed twice with RPMI, and resus-
pended at a concentration of 10' cells/ml in the presence of 5 x 105/ml irradiated (45
Gy) allogeneic EBV-transformed B cells, in KH medium (RPMI 1640, 6 mM Hepes, 0.06
mM 2-ME [Sigma Chemical Co., St. Louis, MO], 1.6 MM L-glutamine, 100 U/ml penicillin,
and 100 ug/ml streptomycin [Gibco Laboratories, Grand Island, NY], 10% heat-inacti-
vated pooled human serum [Flow Laboratories, Inc., McLean, VA]). After 5-7 days,
lymphocytes were cloned by limiting dilution.
Rheumatoid Synovial Membrane. Synovial membranes were obtained from patients
undergoing joint replacement for rheumatoid arthritis in accordance with the human
studies guidelines of the Massachusetts Institute of Technology and the Massachusetts
General Hospital. Membranes were placed in Kmedium (the same as KH medium, except
that 10% heat-inactivated FCS is substituted for human serum) with 30 U/ml rIL-2, and
after 1 wk cells in the supernatant were cloned by limiting dilution.
CTL Cloning by Limiting Dilution.
￿
Aliquots from the bulk T cell cultures were diluted
to 10 viable cells/ml in KH medium to which was added 5% PHA supernatant (15), 50
U/ml human rIL-2 (the gift of Biogen Research Corp., Cambridge, MA), and B cellsplus
cells from the bulk MLC (each at 5 x 105cells/ml and irradiated with 45 Gy). The mixture
was distributed into flat-bottomed 96-well culture plates (Costar, Cambridge, MA) at 0.1
ml/well, equivalent to 1 viable cell/well. After 7 and 14 d, an additional 0.1 ml of KH
medium supplemented with PHA supernatant (5%), IL-2 (50 U/ml), and irradiated (45
Gy) B cells (7.5 x 105/ml) was added to each well. Clones were generally visible after 10-
20 d, and were then expanded into 24-well culture plates. Clones were gradually weaned
to KH medium supplemented with 5% PHA supernatant and 20-25 U/ml rIL-2, and
restimulated at five 10-d intervals. The added B cells were allogeneic EBV-transformed
cells.
Cytotoxicity Assays.
￿
"Cr-release killing assays were performed as described (16); when
measuring lectin-dependent cytolytic activity, Con A (Vector Laboratories, Inc., Burlin-
game, CA) wasadded to a final concentration of 10 /Ag/ml.
PMSF Inhibition ofCytolysis.
￿
Various numbers of T cellswere incubated for 15 min at
37°C in K medium containing PMSF at 0, 2, 4, and 6 mM (PMSF was added in DMSO;
the final concentration of DMSO in all instances was 1%). Cytotoxicity was assayed as
above except that a 2-h assay was used to minimize the effect of new protein synthesis.
T Cell SurfaceMarkers.
￿
mAbs to CD3, CD4, and CD8 (OK-T3, OK-T4 and OK-T8,
Ortho Diagnostic Systems Inc., Westwood, MA) and FITC-labeled rabbit anti-mouse
(Fab')z (CooperBiomedical, Inc., Malvern, PA) were used to stain Tcells (17), whichwere
then analyzed by fluorescence microscopy or in an Ortho Diagnostic Systems Inc. 50 H
flow cytometer.
Serine Esterase Activity.
￿
Enzyme levels were determined as previously described (10).
CTL Membranes.
￿
109 cells of a cloned human CTL cell line, HE-14, were harvested
and the membranes purified and solubilized with 0.5% NP-40 in PBS as previously
described (11); about 97% of the total BLT-esterase activity present in the cell lysate
resided in the pelleted membranes.
Inhibition of Serine Esterase Activity.
￿
Aliquots of NP-40 solubilized HE-14 membranes
containing about 1 U of BLT-esterase activity were diluted to 0.1 ml with 0.5% NP-40 in
PBS, and 2 Al of the following inhibitor solutions were added: PMSF, 100 mM in DMSO;
N-a-p-tosyl-L-lysine chloromethyl ketone (TLCK), 25 mM in DMSO; N-tosyl-L-phenylala-
nine chloromethyl ketone (TPCK), 25 mM in DMSO; anddiisopropylfluorophosphoridate
(DFP), 100 mM in propylene glycol. After 30 min at 37°C, serine esterase activity was
measured as above.
SDS-PAGE of DFP-labeled Cell Extracts.
￿
0.4 ml of NP-40 extracts of the murine CTL
cell line G4 or of HE-14 cell membranes were labeled with 20 ~uCi of 1,3-[sH]DFP in530
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propylene glycol (5.2 Ci/mmol; New England Nuclear, Boston, MA) as described (10),
and subjected to discontinuous SDS-PAGE on a 10% gel as per Laemmli (18). Gels were
briefly stained with 0.1 % Coomassie Brilliant Blue (Bio-Rad Laboratories, Richmond,
CA) to locate molecular weight markers, then after destaining were impregnated with
Autoflour (National Diagnostics, Inc., Somerville, NJ), dried, and exposed at -70°C on
Kodak XAR-5 film (Eastman Kodak Co., Rochester, NY).
pH Optimum of Serine Esterase Activity.
￿
Aliquots containing ^-1 U of BLT-serine
esterase were diluted to 0.1 ml with buffered saline (130 mM of NaCl, 20 mM Tris
phosphate, pH ranging from 5.0-9.5). 10 ul of 20 mM BLT was added, followed after
30 min at room temperature by 0.9 ml of 2.2 mM 5,5'-dithiobis-(2-nitrobenzoic acid)
(DTNB) in 300 mM TrisCl, pH 8 .1 . The absorbance at 412 nm was determined 30 s
later, to allow ample time for the cleaved BLT to react with the DTNB without having
significant amounts of additional enzymatic cleavage of the BLT. At each pH value, the
spectrophotometer was blanked to an identically treated sample free of added esterase, to
control for any pH effect on the spontaneous hydrolysis of BLT .
Dot Blot Analysis of cDNA Inserts.
￿
A agt10 phage cDNA library was constructed from
the human cloned CTL line HE-14 as described (19), and screened with a mixture of
["P]kinase-labeled oligonucleotide probes (20) corresponding to the regions around the
active site serine and histidine residues of the murine HF (21) and C11 (22) genes. The
cDNA insert from one of the identified clones was compared by dot blot analysis (23)
with the insert of a murine cDNA clone known to have a C I 1 sequence (Verret, C. R., E.
B. Reilly, M. S. Pasternack, R. Mattaliano, and H . N . Eisen, manuscript in preparation)
using the individual oligonucleotide probes.
Serine Esterase Secretion by Human CTLs.
￿
CTLs and "Cr-labeled JY targets were
suspended in RPMI 1640 plus 1 mg/ml BSA (Boehringer Mannheim Diagnostics, Inc.,
Houston, TX); 8 X 105 CTLs in 0 .1 ml were added to a variable number of target cells
(also in 0.1 ml) to give final CTL/target ratios ranging from 4:1-0.25:1 . After 3 h at
37'C, the supernatants from duplicate wells were pooled; 50 ul were taken to determine
serine esterase activity, and 75 ul taken to measure release of "Cr. Total esterase activity
in the CTLs was determined from NP-40 lysates; the baseline esterase activity from JY
alone (which is mostly composed of reducing activity rather than enzymatic activity) was
determined by incubating targets without CTLs and treating as above.
Percoll Density Gradient Centrifugation.
￿
CTLs were harvested, washed with PBS, resus-
pended in relaxation buffer (0.1 M KCI, 3 mM NaCl, 3.5 MM MgCl2, 1 .25 mM EGTA
(Sigma Chemical Co.), 10 mM Pipes, pH 6.8, with ATP (both Sigma Chemical Co.) added
to 1 mm just before use and subjected to Percoll density gradient centrifugation as
described (11). After centrifugation, 0.8-ml fractions were collected from the bottom of
the tube using capillary tubing attached to a peristaltic pump. To detect serine esterase
activity, 20-25-u1 aliquots of each fraction were placed in 96-well flat-bottomed assay
plates (Immulon-1 ; Dynatech Laboratories, Inc., Alexandria, VA) and 0.125 ml of a
standard reaction mixture (0.1 mM BLT, 1 mM DTNB in 300 mM TrisCl, pH 8.1) was
added to each well. After 5 min at room temperature, the absorbance at 414 nm was
measured using a Titertek Multiskan scanner (Flow Laboratories, Inc.) blanked to relax-
ation buffer plus reaction mixture alone. Hemolytic activity in 20-50-u1 aliquots was
measured as described (11) using as targets either sheep erythrocytes (Colorado Serum
Co., Boulder, CO ; stored at 4°C in Alsevier's solution, then washed and resuspended in
Hepes-buffered saline just before use) or fresh human erythrocytes (collected sterilly into
sodium-heparin, 25 U/ml, then washed and resuspended in Hepes-buffered saline). ^-3 X
107 erythrocytes were used for each sample. The absorbance of released hemoglobin was
measured at 414 nm on a Titertek Multiskan scanner blanked to PBS.
Freeze-Thaw Assay for Hemolytic Activity.
￿
5 X 10" CTLs (HE-14, ML-4) or murine
CTLs (2C) were washed twice in PBS plus 1 mM EDTA, then resuspended in 0.05 ml of
the same buffer. Samples were frozen in a dry ice-ethanol bath for 10 min, then thawed
in cold water, centrifuged for 5 min at 8,000 rpm and 4°C, and the supernatants were
stored on ice until assayed. Aliquots of supernatants obtained after one, two, and three
freeze-thaw cycles were tested for hemolytic activity as above.FERGUSON ET AL .
￿
53 1
Other Cell Lines. JY (HLA-A2,-B7) was obtained from the Tissue Culture Center at
MIT, and CCRF-SB (HLA-AI,2-B12,17-Cw2) and RPMI 7666 (HLA-A3,w29,-B7,12)
were obtained from the American Type Culture Collection (Rockville, MD). JY and
CCRF-SB were derived by EBV transformation of peripheral blood lymphocytes; RPMI
7666 is a B cell lymphoma line. 6B-7 is a CTL clone derived from a transplanted kidney
during an episode of rejection (24, 25) and was the gift of Dr. James Kurnick, Massachu-
setts General Hospital.
Results
BLT-Serine Esterase Activity.
￿
Table I summarizes the levels of BLT-serine
esterase found in NP-40 lysates of 20 human T cell lines. All but three (1E-12,
ML-47.2, and 5D-4) were cytotoxic, exhibiting 30-80% specific lysis of 5'Cr-
labeled target cells during a 4-h assay at a CTL/target ratio of 20:1 . For
comparison, three human B cell lines and one murine CTL were also assayed.
The murine CTL 2C had an enzyme level (94 U/106 cell equivalents) similar to
that previously described for other cloned murine CTLs (10) . The human B cell
lines had only trace activity in the BLT assay (<0.5 U/106 cells). In contrast, the
level of serine esterase in human cytolytic T cells ranged from 3.9-21 U/106
cells, with an average of 9.1 U/106 cells; no consistent difference was seen
between CD4+ and CD8* cell lines. While the levels in three noncytotoxic CD4'
human T cell lines were perhaps slightly lower than in cytotoxic T cells, they
were distinctly higher than in non-T cells; this is in contrast to murine T cell
lines in long-term culture, where the enzyme levels in nearly all noncytotoxic
(CD4+) T cells is <I% of the level in cytotoxic T cells (10). However, the level
of esterase activity seen in all the human CTL clones was consistently lower than
in murine CTLs.
The levels of BLT-serine esterase activity are very low in murine thymocytes,
but increase more than 50-fold after activation by Con A, in parallel with the
appearance of cytotoxic activity (10). Similarly, the enzyme levels in fresh human
peripheral blood lymphocytes were also very low (^"0.5 U/ 106 cells), but increased
along with the appearance of specific cytolytic activity during the course of a
mixed lymphocyte culture, to 1.5 U/106 cells after 5 d and 3.8 U/106 cells after
12 d.
Inhibitors of BLT-Serine Esterase.
￿
One of the distinguishing features of the
murine T cell-specific serine esterase is its pattern of susceptibility to protease
inhibitors: it is inhibited by PMSF and DFP, but not by TLCK or TPCK (10).
Similarly, after a 20-min incubation at room temperature with 2 mM PMSF, the
human BLT-serine esterase was almost completely inhibited (97% reduction in
esterase activity), whereas a similar incubation with 0.5 mM TLCK or 0.5 mM
TPCK did not significantly inhibit the enzyme (-1% and 4% inhibition, respec-
tively) (Table II). A single addition of 2 mM DFP resulted in only 34% inhibition,
probably because of instability of DFP in an aqueous environment at pH 8;
increased inhibition (to 68%) was seen with a second addition of DFP. As with
murine CTLs (10), preincubating intact human CTLs with PMSF markedly
decreased their cytolytic activity in a 2-h "Cr-release assay (Fig. 1); 15 min in 6
mM PMSF reduced cytotoxicity by ^-75%, while not affecting the viability of
either the CTLs (as assessed by trypan blue exclusion) or the targets (as assessed
by release of "Cr).532
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TABLE I
BLT-DTNB AssayforSerine Esterase Activity
* Whereappropriate, specificity wasdetermined in a 4-h"Cr-release assayusingvarious
B-cell lines as targets (7). LDK, lectin-dependent killer, denotes cellscytolyticonly in
the presence of Con A.
TABLE II
Inhibition ofHE-14 Serine Esterase Activity
Cell line Source Type $pecificity* Esterase
level
U/106 cells
JY EBV-pbl Bcell - 0.2
CCRF-SB EBV-pbl Bcell - 0.3
RPMI 7666 Lymphoma Bcell - 0.1
2C Murine CTL CD8+ H2-Ld 94
HE-14 MLC CD4+ JY 11 .7
HE-17 MLC CD4+ LDK 4.2
HEJ-20 MLC CD4+ JY 21 .0
ML-21 MLC CD4+ JY, CCRF-SB 19.4
HEB-13 MLC CD8+ HLA-B7 9.9
HEB-34 MLC CD8+ HLA-A2 5.8
ML-4 MLC CD8+ HLA-A2 4.1
ML-32 MLC CD8+ HLA-B7 4.6
ML-37.4 MLC CD8+ HLA-A2 15.4
1B-1 MLC CD8+ LDK 9.6
1B-6 MLC CD8+ LDK 4.4
1D-12 MLC CD8+ CCRF-SB 3.1
5C-5 MLC CD8+ LDK 7.5
1B-5 MLC CD8+ LDK 4.2
lA-3 MLC CD8+ LDK 3.9
ID-1 Synovium CD8+ LDK 13.0
6B-7 Renal graft CD8+ ? 11 .4
IE-12 Synovium CD4+ Non-killer 3.4
ML-47.2 MLC CD4+ Non-killer 5.6
5D-4 MLC CD4+ Non-killer 2.2
Inhibitor Concentration Esterase activity Inhibition
MM OD412 %
None - 0.608 -
PMSF 2.0 0.018 97
TLCK 0.5 0.615 1
TPCK 0.5 0.585 4
DFP 1 x 2.0 0.403 34
DFP 2 x 2.0 0.192 68FERGUSON ET AL .
￿
533
FIGURE 1 .
￿
Inhibition of cytolytic activity of a human
clonedCTL cell line (HE-14) by PMSF . HE-14 cells were
preincubated with PMSF for 15 min, then assayed for
killing activity against "Cr-labeledJY. (/) no PMSF ; ([p)
2mM PMSF; (x) 4mM PMSF; (A) 6mM PMSF .
FIGURE 2 .
￿
Relative molecular mass (M,) of [9H]DFP-labeled
proteins in lysates of human and murine cloned CTL cell lines .
NP-40 extracts of murine G4 cells (lanes b and c) or of human
HE-14 cell membranes (lanes a and d) were labeled with 1,3-
[9H]DFPand subjected to discontinuous SDS-PAGE on a 10%
gel . Lanesa and b were run under reducing conditions, cand d
under nonreducing conditions.
SDS-PAGE ofj'HJDFP Labeled BLT-Serine Esterase .
￿
Because human CTLs
exhibit less BLT-serine esterase activity than murine CTLs, only limitedamounts
of [sH]DFP affinity-labeled enzyme from unfractionated cell lysates could be
loaded onto a gel . To overcome this limitation, NP-40-solubilized HE-14 cell
membranes (which contained -97% of the BLT-serine esterase activity present
in these cells) were labeled and subjected to SDS-PAGE under reducing and
nonreducing conditions ; similarly labeled extracts of the murine CTL line G4
were included for comparison (Fig . 2) . As shown in Fig . 2, under reducing
conditions the tritium label from HE-14 appeared predominately in a band of
M,. 31 X 10 s ; the murine cell extract shows a more diffuse band at Mr 30-34 X
l Os. Under nonreducing conditions, the 'H-labeled proteins had a higher appar-
ent molecular mass (Mr -51 X 10' for human and -59 X 10s for mouse),
indicating that the human enzyme, like the mouse enzyme (11, 13) is probably a
disulfide-linked dimer.
pH Dependence ofBLT-Serine Esterase.
￿
ThepH optimum for the BLT-serine
esterase activity in murine CTLs is about 8 (13 ; our unpublished results), much
higher than the optimal pH for macrophage esterases (pH 3-4) . The activity of
the serine esterases from HE-14 cell membranes and 2C whole-cell lysates was
measured at variouspH values ranging from 5 to 9.5 (Fig . 3) . For both enzymes,
activity was negligible at pH 5, and increased in parallel to a maximum at pH 8-
9 .
Homology ofHuman Serine Esterase cDNA With the MurineHF Gene.
￿
To further534
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His Ser
FIGURE 3 .
￿
pH dependence of serine esterase activity in
human and murine CTLs. Equal aliquots of NP-40 solu-
bilized whole cell lysate (mouse) or cell membranes (hu-
man) were assayed for amount of BLT-serine esterase
activity at various pH values . (/) human CTL clone HE-
14 ; (0) mouse CTL clone 2C .
FIGURE 4 .
￿
Hybridization of inserts from human
and mouse cDNA clones with oligonucleotide
probes derived from genes for two murineT cell-
specific serine esterases(HF and C11) . A mixture
of oligonucleotide probes with sequences corre-
sponding to regions around the active site serine
and histidine residues of the mouse HF and CII
genes was used to screen a agt10 phage cDNA
library from the human cloned CTL cell line HE-
14 . The cDNA insert from one of the identified
clones (Hu) wascompared by dot blot analysis with
the insert of a mouse cDNA clone (Mo) known to
have theCI I sequence (Verret, C. R., et al ., man-
uscript in preparation) . In the blots shown, the
four ["P]kinase-labeled oligonucleotide probes
were used individually : HF at the serine-183 (Ser)
and histidine-41 (His) sites (21) and C11 at the
serine-184 (Ser) and histidine-44 (His) sites (22) .
inRNA dot blot assays, it reacted consistently with
RNAfrom humanT cell lines; it also reacted with
two EBV-transformed B cell lines, but not with a
human B cell lymphoma cell line (data notshown) .
Thefour probes are shown below .
characterize the human BLT-serine esterase, a cDNA library was constructed
from the human CTL line HE-14 and screened with a mixture of synthetic
oligodeoxynucleotide probes corresponding in sequence to the regions around
the active site serine (Ser) and histidine (His) residues of the murine serine
esterase genes termed HF (21) and C11 (22) . Dot blots of the insert from one of
the strongly hybridizingcDNA clones, together with a previously isolated murine
cDNA clone having a sequence identical to the published sequence for murine
C11, were separately hybridized with each of the oligonucleotide probes (Fig .
4) . The human cDNA clone hybridized strongly with the His probe from the
murine HF gene but not with the Hisprobe from the murine C11 gene, indicating
homology between the human cDNA clone and the murine HF gene . The
intensity of hybridization to the Ser probes also support this conclusion, although
less definitively because the probes crosshybridize with both the murine HF and
C11 genes .
Serine Esterase Secretion.
￿
Many murine CTLs release some (10-60%) of their
total serine esterase activity into the medium when they interact with an excess
of their target cells (11, 26) . Two human CTL lines (HE-14, HEJ-20) were
similarly tested for serine esterase secretion when incubated with up to a fourfold
excess of the appropriate "Cr-labeled target cells . No significantrelease ofBLT-FIGURE 5. Percoll density gradient
centrifugation of nitrogen-cavitated hu-
man and murine CTLs. Fractions were
monitoredforserine esterase activity (/)
and for hemolytic activity (O, when
measured with sheep erythrocytes; p,
when measured with fresh human eryth-
rocytes). Number of cellsanalyzed: (a) 5
x 10' HEB-13; (b) 1.4 x 10 HEB-34;
(c) 5 x 107 1D-1 ; (d) 5 x 107 ML-32; (e)
8 x 107 ML-4; (f) 9 x 107 HEJ-20; (g) 1
x 108 HE-14; (h) 1 x 108 HE-14 + 2 x
1072C. Only the2C cells were ofmurine
origin.
serine esterase activity into the medium was detected over 3 h, although consid-
erable target cell lysis (as high as 0.8 target cell lysed per CTL) was observed.
PercollDensityGradient Centrifugation. When disrupted by nitrogen cavitation
and subjected to discontinuous Percoll gradient centrifugation, murine CTLs
exhibit both a large high-density peak of BLT-serine esterase activity that
coincides with the peak of hemolytic activity, and a small low-density peak of
BLT-serine esterase activity (11, 12). Seven human CTL lines (two CD4+, five
CD8+) were similarly analyzed by Percoll density centrifugation (Fig. 5, a-g).
Each gradient exhibited two peaks of activity, with the high-density peak being
only about the same size as the low-density peak, instead of much larger as with
murine CTLs .
Hemolytic Activity.
￿
As shown in Fig. 5, none of the Percoll gradients contained
any hint of hemolytic activity, even when thealiquots tested were 20 times larger
than those sufficient to demonstrate considerable hemolysis from murine CTL
lines. To test the possibility that this lack of hemolytic activity was due to the
presence of an inhibitor, rather than the absence of the hemolytic protein per
se, 10" HE-14 cells were mixed with 2 x 107 murine CTL (2C) cells, and the
mixture subjected to nitrogen cavitation and Percoll density centrifugation (Fig.
5h). The amount and position of the peak with hemolytic activity from the
murine CTL 2C matched the results from gradients prepared from 2C alone,
and coincided with the high-density serine esterase peak. Thus, the absence of
hemolytic activity in the human CTL cell lysate was not due to the presence of
an inhibiting substance, at least not one that was also capable of inhibiting the
murine hemolytic activity. The location of the murine and human high-density
BLT-serine esterase peaks coincided in this experiment and also when separate
gradients of murine cells and HE-14 were run in parallel (data not shown).536
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TABLE III
Hemolytic Activity AfterFreeze-Thaw Lysis ofMurine and Human CTLs
Detergent lysis of erythrocytes, which resulted in an absorbance of 2.416, was taken as 100%
hemolysis; untreated erythrocytes (spontaneous hemolysis) resulted in an absorbance of 0.074.
To look for hemolytic activity by an alternative method, we assayed suspensions
of freeze thawed cells (27) from two human CTL lines (HE-14, ML-4) in parallel
with the murine CTL line 2C. As can be seen in Table 111, the hemolytic activity
from murine CTLs is easily detected in this manner; in contrast, detectable
hemolytic activity was not released from the human CTLs.
Discussion
Taken together, all ofthese results show that cloned human T cell lines contain
a homologue of the murine T cell-specific BLT-serine esterase. The human
and murine enzymes are similar in several respects: (a) both are expressed in T
cells but not in B cells; (b) they have similar patterns of inhibition by small
organic molecules (i.e., they are inhibited by PMSF and DFP, but not by TLCK
or TPCK); (c) both enzymes can be affinity labeled with [3H]DFP, and SDS-
PAGE analysis under reducing conditions revealed the labeled proteins to have
similar apparent molecular weights (Mr ^"30 X 103 for the human enzyme and
-30-34,X 103 for the murine enzyme) ; (d) a cDNA clone from a library prepared
from a human cloned T cell line (HE 14) hybridized with two synthetic oligo-
nucleotide probes that correspond to nucleotide sequences surrounding the
active site serine and histidine of the HF gene, which encodes the principal
murine T cell-specific BLT-serine esterase (28); (e) just as the BLT-serine
esterase activity in murine thymocytes increases markedly after stimulation with
Con A, the activity in human peripheral blood lymphocytes also increased after
allogeneic stimulation.
However, there are also some important differences between the murine and
human BLT-serine esterases: (a) the enzyme level in the cloned human T cell
lines is only about one-tenth that present in cloned murine CTLs; (b) whereas
with murine T cells it was found initially that the enzyme is expressed at high
levels (30-200 U/106 cells) in cytolytic clone T cell lines but not in noncytolytic
(helper) cloned T cell lines (which typically had <_1 U/106 cells), we have seen
Number
of freeze-
thaw
cycles
CTL cell
equivalents
tested
Hemoglobin release (specific
2C HE-14
(murine) (human)
hemolysis)
ML-4
(human)
OD414 % OD414 % OD414 %
1 2 x 106 2.073 85 0.056 -1 0.062 -1
1 X 106 2.379 98 0.059 -1 0.058 -1
2.5 X 106 2.369 98 0.053 -1 0.057 -1
2 2 X 106 0.415 15 0.068 0 0.051 -1
1 X 106 2.312 96 0.046 -1 0.057 -1
2.5 X 106 2.397 99 0.050 -1 0.051 -1
3 2 X 106 0.148 3 0.055 -1 0.069 0
1 X 106 1.710 70 0.050 -1 0.058 -1
2.5 X 106 2.152 89 0.054 -1 0.059 -1FERGUSON ET AL.
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here that in the cloned human T cell lines the enzyme is present at about the
same level in both cytolytic (either CD4+,CD8- or CD4-,CD8') and noncytolytic
(CD4'',CD8-) lines. Interestingly, a recent study has shown that, in mice also, the
CD8' (Lyt-2') and CD4 (L3T4') bulk T cell populations derived from 6-d
mixed lymphocyte cultures have similar levels of BLT-serine esterase, despite
substantial difference in cytolytic activity (27). It is possible that the previously
observed differences between cytolytic and noncytolytic murine CTLs is a
consequence of these cells having been maintained in culture for long periods
(i.e., 1-5 yr); the cloned human T cell lines tested here were in culture for no
longer than 6 mo ; (c) most murine CTLs are triggered to secrete their BLT-
serine esterase by interaction with target cells; two similarly stimulated human
CTL clones did not release a detectable level of BLT-serine esterase during
interaction with their target cell; (d) the apparent molecular weights of the
reduced and nonreduced [3H]DFP-labeled human enzyme are ^-31 X 103 and
51 X 103, respectively, whereas the corresponding values for the murine enzyme
are 30-34 X 103 and 59 X 103, respectively. While the murine enzyme is
probably a homodimer (11, 13), the present data would suggest that the human
enzyme exists as a heterodimer consisting of a DFP-reactive subunit of ^"31 X
103 M,. and a nonreactive subunit of -20 X 103 M, ; however, the possibility that
the human enzyme is a homodimer with an unusually high electrophoretic
mobility cannot be ruled out. It may be noted parenthetically that other human-
mouse homologues differ structurally to a surprising extent: the CD8 glycopro-
tein is a homodimer on human T cells but a heterodimer (Lyt-2,3) on murine T
cells (29).
Perforin plays a central role in the exocytosis model of target cell destruction
by CTLs (2-6) and NK cells (30-33). It was therefore surprising that in none of
the 17 human CTL clones analyzed could we find evidence of hemolytic activity
using procedures that readily reveal such activity in cloned murine CTLs. Since
the human CTLs do not contain a demonstrable inhibitor of perforin activity, it
would appear that if perforin activity is present at all, it is either at exceedingly
low levels (<2% of the level in mouse cells) (33) or in an unusually labile form.
Whether perforin content of cells strictly parallels perforin hemolytic activity is
not known. Recent observations by Berke (34) and others (e.g., 35-38) suggest
that release of cytolytic granules with their included perforin may not be the
only mechanism by which murine CTLs can rapidly destroy target cells. The
absence of the characteristic hemolytic activity of perforin, the lack of detectable
serine esterase secretion during interaction with specific target cells, and, per-
haps, the low overall level of BLT-serine esterase, all suggest that the human
CTLs examined may likewise kill their target cells by a perforin-independent or
granule-independent mechanism.
Summary
Target cell lysis by most murine cytotoxic T lymphocytes appears to be
mediated by a complement (C9)-like protein called perforin, contained in high-
density cytoplasmic granules. These granules also contain high levels of serine
esterase activity, which may also play a role in cytolysis. Analysis of 17 cloned
human cytotoxic T lymphocytes revealed the presence of serine esterase that is53 8
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very similar to its murine counterpart in substrate and inhibitor specificities, pH
optimum, and molecular mass; dot blot hybridization with synthetic oligonucle-
otides corresponding to the active sites of two known murine CTL esterases
suggests homology to the murine enzyme HE However, serine esterase was
present at only ^-10% of the level found in murine CTLs, and was not secreted
during CTL-target cell interaction; moreover, hemolytic activity could not be
detected in any of the seven cell lines tested. The results suggest that the human
CTLs examined here kill their target cells by a mechanism different from that
used by most cloned murine CTLs.
Receivedfor publication 14 August 1987 and in revised form 20 October 1987.
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